When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
JNJ - Astellas' roxadustat successful in late-stage anemia study
Johnson & Johnson
Astellas Pharma (OTCPK:ALPMF) announces positive results from a Phase 3 clinical trial, DOLOMITES, evaluating roxadustat for the treatment of anemia in non-dialysis-dependent adults with stage 3-5 chronic kidney disease. The data were virtually presented at the European Renal Association-European Dialysis and Transplant Association Congress.
More news on: Astellas Pharma Inc., Amgen Inc., FibroGen, Inc., Healthcare stocks news,